Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dean E. Brenner, MD
University of Michigan Rogel Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tulane University School of Medicine
New Orleans, Louisiana, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, United States
- Veterans Affairs Medical Center - Dallas
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 1995
- Primary completion
- 30 Jun 2002
- Completion
- 31 Oct 2005
- Last update posted
- 19 Dec 2012
- Registered enrollment
- 152
- Registry id
- NCT00003076
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.